Tilray Shares Face Mounting Pressure as US Regulatory Shift Unfolds

The Canadian cannabis producer Tilray is confronting intensified selling pressure as a recent legislative change in the United States casts a shadow over its strategic ambitions. This development represents a significant obstacle for the company’s long-term plans to expand within the US market.

Friday’s trading session saw Tilray shares decline by 4.42% to close at $1.08, marking the second consecutive day of substantial losses. Trading activity surged 18% above average levels as investors exited positions, reflecting heightened market anxiety.

The downturn was triggered by a late addition to a US federal budget bill that effectively re-criminalizes certain popular hemp-derived THC products, including Delta-8 THC. These products had operated in a Read more...